The short answer
HTLV-1 is a virus spread through blood, sex, and breastfeeding. In a small share of those infected, it causes adult T-cell leukemia/lymphoma, often decades later. Safer practices and screening reduce spread.
Human T-cell lymphotropic virus type 1 is classified as a known human carcinogen (IARC Group 1).
People are mainly exposed by spread through breastfeeding, sex, and infected blood.
It is most strongly linked to adult T-cell leukemia/lymphoma.
A carcinogen classification describes hazard — whether something can cause cancer — not your personal risk at a given exposure.
Choose how you want to understand this
The full explanation.
The simple version
HTLV-1 is a virus found more often in certain parts of the world. Most infected people stay healthy. A small share develop a blood cancer called adult T-cell leukemia/lymphoma, often many years after infection.
What human t-cell lymphotropic virus type 1 is
Human T-cell lymphotropic virus type 1 (HTLV-1) infects a type of white blood cell. It is more common in parts of Japan, the Caribbean, Africa, and South America. Most carriers never develop disease. Infection lasts for life, and it carries a small cancer risk.
How people are exposed
Common ways people come into contact with it:
- Breastfeeding from an infected mother.
- Unprotected sex, and contact with infected blood.
- Sharing needles. Rarely, blood transfusion where blood is not screened.
The cancer connection
HTLV-1 causes adult T-cell leukemia/lymphoma. It appears in a small fraction of carriers, usually decades after infection. The World Health Organization estimates the lifetime risk of this leukemia at about 5% for people with the infection. Only about 5% to 10% of infected people develop any HTLV-1 illness at all.
The International Agency for Research on Cancer (IARC), the cancer arm of the World Health Organization, places HTLV-1 in Group 1, carcinogenic to humans. That is the strongest evidence category. It means there is enough evidence that HTLV-1 can cause cancer in people.
Hazard is not the same as risk
A Group 1 listing describes hazard. It says HTLV-1 can cause cancer under some conditions. It does not describe any one carrier's risk. Most people who carry HTLV-1 never develop leukemia or lymphoma. The listing tells you what the virus is capable of. It does not tell you what will happen to a given person.
How to lower your exposure
- Blood screening in many countries reduces spread through transfusion.
- Safer sex, and not sharing needles, lower transmission.
- Mothers with HTLV-1 are advised about feeding options. WHO puts the risk of passing the virus through breastfeeding at 20% to 30%, and shorter nursing lowers it.
- There is no vaccine for HTLV-1 at this time.
Any single exposure is one piece of a larger picture. See our overview of cancer prevention and what raises cancer risk.
The bottom line
HTLV-1 is a known human carcinogen (IARC Group 1). For most carriers, the practical steps are about not passing the virus on. Screening, safer sex, and clean needles do most of that work.
Sources
Words to know
Tap any term to see what it means.

Common questions
Does human t-cell lymphotropic virus type 1 cause cancer?
Yes. Human T-cell lymphotropic virus type 1 is classified as a known human carcinogen, which means there is strong evidence it can cause cancer in people. How much any one person's risk rises depends on how much they are exposed to and for how long.
How are people exposed to human t-cell lymphotropic virus type 1?
Most exposure happens by spread through breastfeeding, sex, and infected blood.
Which cancers are linked to human t-cell lymphotropic virus type 1?
It is most strongly linked to adult T-cell leukemia/lymphoma.
How can I reduce my exposure to human t-cell lymphotropic virus type 1?
The main steps are blood screening, safer sex, and not sharing needles.
Does a carcinogen label mean I will get cancer?
No. A classification is about hazard — whether human t-cell lymphotropic virus type 1 can cause cancer under some conditions — not a prediction that any one exposed person will develop cancer. Your actual risk depends on the amount and length of exposure and other factors.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 2 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-11Next planned review: 2028-07-05
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share
